drugset / Trial / NCT01279213
Clozapine/Paliperidone Versus Clozapine/Placebo in Resistant Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
augmentation of clozapine with paliperidone in the treatment of resistant schizophrenia has not been tested until now in randomized controlled trials. This combination is supposed to have therapeutic efficacy in the treatment of resistant schizophrenia.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-10
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Paliperidone | Unknown | 3 mg | Oral |
| Comparator | Paliperidone | Unknown | 6 mg | Oral |
| Comparator | Paliperidone | Unknown | 9 mg | Oral |
| Comparator | Paliperidone | Unknown | 12 mg | Oral |
| Comparator | Clozapine | Other / unclassified | — | — |